Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Symphony Ltd has fixed July 17, 2026 as record date for a ₹5 FY26 final dividend and will hold its 39th AGM virtually on August 4.
ACS Technologies approved a ₹20 crore preferential issue to convert unsecured loans into equity, while BSE cleared listing of 86.95 lakh shares issued after warrant conversions.
Timken India reported Q1 FY27 standalone PAT of ₹115.13 crore on revenue of ₹929.09 crore, alongside BIS licenses and progress on merging its wholly owned subsidiary.
Hindustan Foods is at ₹551 ahead of July-August 2026 results, with Q1 FY27 revenue seen at ₹1,082-1,245 crore and PAT at ₹37-47 crore, alongside a ₹615-686 target range.
Jay Bharat Maruti reported higher Q1 FY27 revenue but lower profit year-on-year, as the board approved unaudited results and announced a new independent director appointment.
MCX posted a sharp YoY jump in Q1 FY27 profit and operating income, while outlining upcoming key dates including its AGM, dividend process, and investor call schedule.
Jay Bharat Maruti’s Q1 FY27 revenue rose to ₹630.16 crore, but standalone profit fell to ₹21.24 crore as cost pressures and lower incentives weighed on margins.
MCX reported Q1 FY27 profit of ₹413.44 crore and revenue from operations of ₹702 crore, while also announcing its 24th AGM date and upcoming investor call.
India’s Closing Auction Session for F&O stocks is reshaping closing price discovery, creating Day 1 volatility and timing changes that traders, funds, and brokers must adapt to.
SEBI’s Closing Auction Session (CAS) begins August 3, 2026 for F&O-eligible stocks, replacing the last-30-minute VWAP close with an auction-based equilibrium price.
NHPC’s board meets on August 4, 2026 to approve June-quarter results, with broker estimates pointing to higher revenue but a softer profit versus last year.
Sanofi reported Q2 2026 constant-currency sales growth of 17.8% and business EPS of €2.09, while its India consumer healthcare unit posted 7% revenue growth.
Sanofi Consumer Healthcare India reported Q2 FY2026 revenue of ₹235.7 crore and profit of ₹68.8 crore, and confirmed newspaper publication of its unaudited results notice.
ONGC’s board meets on August 04, 2026 to approve Q1 FY27 unaudited results, with consensus pointing to lower revenue but higher PAT amid stronger crude prices.
Sanofi Consumer Healthcare India posted higher Q2 CY2026 revenue and profit, while parent Sanofi reported double-digit sales growth and raised its full-year 2026 sales growth guidance.
Sanofi Consumer Healthcare India disclosed its Q2 2026 unaudited results and publication details, reporting ₹235.7 crore revenue, higher profit, and a clean limited review report.